וואקיקס 18 מג ישראל - עברית - Ministry of Health

וואקיקס 18 מג

truemed ltd, israel - pitolisant as hydrochloride - טבליות מצופות פילם - pitolisant as hydrochloride 17.8 mg - pitolisant

וואקיקס 4.5 מג ישראל - עברית - Ministry of Health

וואקיקס 4.5 מג

truemed ltd, israel - pitolisant as hydrochloride - טבליות מצופות פילם - pitolisant as hydrochloride 4.45 mg - pitolisant

אילומדין ישראל - עברית - Ministry of Health

אילומדין

bayer israel ltd - iloprost - תרכיז להכנת תמיסה לאינפוזיה - iloprost 0.1 mg/ml - iloprost - iloprost - peripheral arterial occlusive disease (stage 3 and 4 of fontaine's classification) in advanced arteriosclerosis, in whom surgery or angioplasty therapy is not possible.thromboangitis obliterans (buerger's disease) with critical limb ischemia in cases where revascularisation is not indicated and severe disabling raynaud's phenomenon .

ונטויס ישראל - עברית - Ministry of Health

ונטויס

bayer israel ltd - iloprost - תמיסה לשאיפה - iloprost 0.01 mg/ml - iloprost

סטאלבו   10025200 מג ישראל - עברית - Ministry of Health

סטאלבו 10025200 מג

inovamed pharma ltd, israel - carbidopa; entacapone; levodopa - טבליות מצופות פילם - levodopa 100 mg; carbidopa 25 mg; entacapone 200 mg - levodopa - levodopa - treatment of patients with parkinson's disease and end-of-dose motor fluctuations not stabilised on levodopa/dopa decarboxylase (ddc) inhibitor treatment.

סטאלבו   5012.5200 מג ישראל - עברית - Ministry of Health

סטאלבו 5012.5200 מג

inovamed pharma ltd, israel - carbidopa; entacapone; levodopa - טבליות מצופות פילם - levodopa 50 mg; carbidopa 12.5 mg; entacapone 200 mg - levodopa and decarboxylase inhibitor - levodopa and decarboxylase inhibitor - treatment of patients with parkinson's disease and end-of-dose motor fluctuations not stabilised on levodopa/dopa decarboxylase (ddc) inhibitor treatment.

אבילק סירופ ישראל - עברית - Ministry of Health

אבילק סירופ

padagis israel pharmaceuticals ltd, israel - lactulose - סירופ - lactulose 66.7 g / 100 ml - lactulose - lactulose - constipation. acute and chronic hepatic encephalopathy.

פונגימון ישראל - עברית - Ministry of Health

פונגימון

trima israel pharmaceutical products maabarot ltd - aluminium chlorohydrate; undecenoic acid; zinc undecenoate - אבקה - undecenoic acid 3 g / 100 g; aluminium chlorohydrate 3 g / 100 g; zinc undecenoate 18 g / 100 g - other antifungals for topical use - for prophylaxis and treatment of fungal infections of the skin especially "athletes foot".

טינדן ג'ל ישראל - עברית - Ministry of Health

טינדן ג'ל

trima israel pharmaceutical products maabarot ltd - dimetindene maleate - ג'ל - dimetindene maleate 0.1 %w/w - dimetindene

יוקריאס 50/850 מ"ג ישראל - עברית - Ministry of Health

יוקריאס 50/850 מ"ג

novartis pharma services ag - metformin hydrochloride 850 mg; vildagliptin 50 mg - film coated tablets - metformin - eucreas is indicated in the treatment of type 2 diabetes mellitus:• eucreas is indicated in the treatment of type 2 diabetes patients who are unable to achieve sufficient glycemic control at their maximally tolerated dose of oral metformin alone or who are already treated with the combination of vildagliptin and metformin as separate tablets.• eucreas is indicated in combination with a sulphonylurea (i.e. triple combination therapy) as an adjunct to diet and exercise in patients inadequately controlled with metformin and a sulphonylurea.• eucreas is indicated in triple combination therapy with insulin as an adjunct to diet and exercise to improve glycaemic control in patients when insulin at a stable dose and metformin alone do not provide adequate glycaemic control.